Yara has today transferred to Fernanda Lopes Larsen, Yara EVP, Africa & Asia, member of Yara's Group Executive Board, a total of 2,129 Yara shares (ticker: YAR, ISIN: NO0010208051) at an average price ...

Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market MIRAMAR, Fla., (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), ...

The DJSI, managed by S&P Dow Jones Indices, is one of the world’s most prestigious and widely recognized benchmarks for corporate sustainability. It evaluates companies based on Environmental, Social, ...

About Replimune Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of novel oncolytic immunotherapies.

DENVER, COLORADO, (GLOBE NEWSWIRE) -- authID ® (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced it has become a member of the ...

White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the " Company ") is pleased to announce the closing of the first tranche of a non-brokered private placement for aggregate gross proceeds of ...

Giftify management decided to cancel the offering due to market conditions.

Novautek is a subsidiary of Applied Development Holdings Limited (HKEX stock code: 519.HK), specializing in the areas of ...

VYN202 induced a dose-dependent increase in the target engagement biomarker HEXIM-1 1 with a maximal effect observed at 0.5mg to 1.0 mg QD. VYN202 inhibited the production of multiple inflammatory ...

Roseland, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

FlexShopper has extended the expiration of the rights offering to 5:00 pm ET on Friday, January 10, 2025 (the “Extended Expiration Time”). Only shareholders that exercise their initial units will ...